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ORIGINAL ARTICLE

Fitness and Mortality Among Persons 70
Years and Older Across the Spectrum of
Cardiovascular Disease Risk Factor Burden:
The FIT Project
Seamus P. Whelton, MD, MPH; Paul A. McAuley, PhD; Zeina Dardari, MS;
Olusola A. Orimoloye, MD, MPH; Erin D. Michos, MD, MHS;
Clinton A. Brawner, PhD; Jonathan K. Ehrman, PhD; Steven J. Keteyian, PhD;
Michael J. Blaha, MD, MPH; and Mouaz H. Al-Mallah, MD, MSc
Abstract
Objective: To determine whether ﬁtness could improve mortality risk stratiﬁcation among older adults
compared with cardiovascular disease (CVD) risk factors.
Methods: We examined 6509 patients 70 years of age and older without CVD from the Henry Ford
ExercIse Testing Project (FIT Project) cohort. Patients performed a physician-referred treadmill stress
test between 1991 and 2009. Traditional categorical CVD risk factors (hypertension, hyperlipidemia,
diabetes, and smoking) were summed from 0 to 3 or more. Fitness was grouped as low, moderate, and
high (<6, 6 to 9.9, and 10 metabolic equivalents of task). All-cause mortality was ascertained
through US Social Security Death Master ﬁles. We calculated age-adjusted mortality rates, multivariable adjusted Cox proportional hazards, and Kaplan-Meier survival models.
Results: Patients had a mean age of 754 years, and 3385 (52%) were women; during a mean followup of 9.4 years, there were 2526 deaths. A higher ﬁtness level (P<.001), not lower CVD risk factor
burden (P¼.31), was associated with longer survival. The age-adjusted mortality rate per 1000 personyears was 56.7 for patients with low ﬁtness and 0 risk factors compared with 24.9 for high ﬁtness and
3 or more risk factors. Among patients with 3 or more risk factors, the adjusted mortality hazard was
0.68 (95% CI, 0.61 to 0.76) for moderate and 0.51 (95% CI, 0.44 to 0.60) for high ﬁtness compared
with the least ﬁt.
Conclusion: Among persons aged 70 years and older, there was no signiﬁcant difference in survival of
patients with 0 vs 3 or more risk factors, but a higher ﬁtness level identiﬁed older persons with good
long-term survival regardless of CVD risk factor burden.
ª 2021 Mayo Foundation for Medical Education and Research
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isk stratiﬁcation in persons 70 years
of age and older presents a signiﬁcant
challenge
because
with
increasing age, there is both an increased
prevalence of cardiovascular disease (CVD)
risk factors and a reduction in their predictive strength.1-3 There is also a higher absolute rate of both CVD and non-CVD
morbidity and mortality in older age, which
contributes to an increase in competing
risks.4-6 Accordingly, for older persons, age

n
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functions as the dominant predictor in
most of the commonly used risk prediction
models, leading to nearly all individuals 70
years and older being classiﬁed as high
risk, whether they have 0 or multiple CVD
risk factors.7-9 Whereas CVD risk factors
are most strongly associated with CVD outcomes, they are notably also associated
with an increased risk for total mortality,
an especially important outcome to consider
among older persons.10-14 Therefore,

Mayo Clin Proc. n September 2021;96(9):2376-2385 n https://doi.org/10.1016/j.mayocp.2020.12.039
www.mayoclinicproceedings.org n ª 2021 Mayo Foundation for Medical Education and Research
Downloaded for Anonymous User (n/a) at Henry Ford Hospital / Henry Ford Health System (CS North America) from ClinicalKey.com by
Elsevier on September 29, 2021. For personal use only. No other uses without permission. Copyright ©2021. Elsevier Inc. All rights reserved.

FITNESS AND CVD RISK FACTORS IN PERSONS 70 YEARS AND OLDER

additional variables are needed to improve
risk stratiﬁcation among older individuals.
Although ﬁtness is not included in
commonly used risk scores, it is one of the
strongest predictors for the risk of both
CVD and total mortality in the general population, and among middle-aged persons,
treadmill exercise testing abnormalities
signiﬁcantly improve risk stratiﬁcation
beyond traditional CVD risk factors.15-22
However, ﬁtness decreases with age, and its
utility for risk stratiﬁcation is less well
deﬁned among older individuals.23 It is uncertain whether older individuals have differences in their mean ﬁtness level across a
low vs high CVD risk factor burden. In addition, it is unknown whether the association
between ﬁtness and mortality differs by
risk factor burden. Therefore, we sought to
determine the association between ﬁtness
and mortality among persons 70 years of
age and older across the spectrum of CVD
risk factor burden.
METHODS
The Henry Ford ExercIse Testing Project
(FIT Project) is composed of 69,885 patients
who performed a physician-referred exercise
treadmill stress test between January 2,
1991, and May 27, 2009, at the Henry Ford
Hospital (Detroit, Michigan) and afﬁliated
medical centers. A detailed description of
the study design, methods, follow-up, and
mortality ascertainment has been previously
reported.24 For this analysis, we excluded
patients who were younger than 70 years
(n¼60,488), those with prior CVD
(n¼2776), and those missing data on ﬁtness
(n¼112), for a total of 6509 persons 70 years
of age and older who were included in this
study.
Treadmill stress testing was performed
using a standard Bruce protocol per the
American Heart Association/American College of Cardiology guideline recommended
methodology.25,26 The test was stopped if
the patient had exercise-limiting symptoms
as determined by the supervising clinician
(clinical exercise physiologist or nurse) or
if the patient requested that the test be
stopped. The test was also stopped if the

patient had an abnormal blood pressure
response (eg, a decrease in systolic blood
pressure of >10 mm Hg despite an increased
workload, systolic blood pressure >250 mm
Hg, or diastolic blood pressure >115 mm
Hg), signiﬁcant ST-segment changes, clinically signiﬁcant arrhythmia, or exerciselimiting chest pain. The patients’ peak exercise workload (peak treadmill speed and
peak incline) was used to calculate their
maximal exercise capacity (eg, ﬁtness),
which was reported as metabolic equivalents
of task (METs). Fitness was categorized as
low (<6 METs), moderate (6-9 METs), and
high (10 METs).27 We chose 10 METs
and higher as the high-ﬁtness group because
older persons have a lower mean ﬁtness level
and few patients in this study achieved 12
METs or more (n¼74). We used physician
referral information to group the stress test
indications into common categories, such
as chest pain and dyspnea.24
Immediately preceding the treadmill
stress test, a trained nurse or clinical exercise
physiologist obtained a medical history
including the patient’s demographic characteristics, CVD risk factors, current smoking
status, current medication use, and past
medical history. This self-reported information was supplemented by a retrospective
search of the administrative databases or
pharmacy claims ﬁles for patients who
were enrolled in the Henry Ford Health System integrated health plan to augment the
information on medication use and past
medical history. For an electronic medical
record (EMR) diagnosis to be coded as
such in our database, it must have been present on at least 3 separate clinical encounters.24 We used these data combining
patient self-report, use of a disease-speciﬁc
medication, or an EMR databaseeveriﬁed
diagnosis to classify hypertension, dyslipidemia, diabetes, and current smoking as present or absent.
The reported resting systolic and diastolic blood pressures were measured immediately before the stress test, but these values
were not used to deﬁne hypertension for this
study because a diagnosis of hypertension
must be based on 2 separate measurements
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on at least 2 separate visits, patients may
have had higher than typical blood pressures
on the day of their stress test because of
withholding of medications for the stress
test, and it was not recorded whether the
blood pressure readings were measured
with the patient in the standing or supine
position. A family history of coronary artery
disease was deﬁned as the presence of a ﬁrstdegree relative with a prior clinical coronary
artery disease event. For patients 80 years
and older, an age of 79 years was used to
calculate the pooled cohort equations
(PCEs) as recommended by the American
College of Cardiology/American Heart Association because the PCEs were developed using individuals aged 40 to 79 years. We
performed a retrospective search of the
EMR and associated laboratory databases to
identify laboratory values obtained within
90 days of the stress test. There were 614
participants missing laboratory data for total
cholesterol concentration, but EMR data for
a diagnosis of hyperlipidemia or lipidlowering medication use were available for
these patients. All-cause mortality was obtained by linkage to the Social Security
Death Master File through April 2013.24
Each patient’s traditional CVD risk factor
(hypertension, dyslipidemia, diabetes, and
smoking) burden was summed from 0 to 3
or more, and the proportion of individuals
within each risk factor group was stratiﬁed
by ﬁtness categories. The age-adjusted mortality rate was calculated per 1000 personyears of follow-up stratiﬁed by METs and
ﬁtness groups. Kaplan-Meier survival analysis was performed on the basis of the number of CVD risk factors and ﬁtness
categories.28 The primary outcome was allcause mortality. Follow-up was calculated
as the days between the exercise stress test
date and the date of death or the end date
for death matching (April 30, 2013). In addition, we performed multivariable adjusted
Cox proportional hazards modeling to
examine the risk of mortality based on the
number of traditional CVD risk factors and
ﬁtness.29 In our adjusted analyses, model 1
included age, sex, race, and reason for the
stress test; model 2 additionally included
2378
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resting systolic and diastolic blood pressure,
total cholesterol concentration, high-density
lipoprotein cholesterol concentration, use of
hypertension medication, use of lipidlowering medication, diabetes, and smoking
status. We performed sensitivity analyses
excluding patients with a diagnosis of cancer
at baseline (n¼777; deﬁned as an EMR-listed
diagnosis), stratiﬁed by sex, and excluding
patients who died within the ﬁrst year of
follow-up (n¼107).
RESULTS
Patients ranged in age from 70 to 96 years,
with a mean age of 75 years (SD 4.2 years);
3385 (52%) were women, and 4603
(70.7%) were White (Table 1). Medication
treatment for the risk factors occurred
among 4269 (79%) patients with hypertension, 1766 (54%) patients with dyslipidemia,
and 714 (43%) patients with diabetes (71
(10%) of whom were prescribed insulin). Patients who reported current smoking
received smoking cessation advice per their
referring physician’s standard practice. The
proportion of patients with CVD risk factors
was lower with higher ﬁtness levels
(Supplemental Table 1, available online at
http://www.mayoclinicproceedings.org).
There were 2526 deaths during a mean
follow-up of 9.4 years. The mean 10-year
PCE risk score was 35.3%, and only 0.2%
(n¼10) had a 10-year PCE score below
7.5%. The CVD risk factor burden was
similar for patients across ﬁtness levels;
6125 (94.1%) patients had at least 1 CVD
risk factor, whereas 1868 (28.7%) patients
had 3 or more CVD risk factors (Figure 1).
Regardless of the number of CVD risk factors, individuals in the low-ﬁtness group
had the highest age-adjusted mortality rate
(56.7 per 1000 person-years), whereas patients in the highest ﬁtness group had the
lowest age-adjusted mortality rate (25.1 per
1000 person-years). In addition, within
each ﬁtness group, the age-adjusted mortality rate did not increase with a higher CVD
risk factor burden (Figure 2). During 15
years of follow-up, there was no signiﬁcant
difference in survival for patients with
0 CVD risk factors compared with those
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TABLE 1. Participant Characteristics Stratiﬁed by Number of Risk Factorsa,b,c
No. of risk factors
Age (y)

0 (n¼384)

1 (n¼1743)

2 (n¼2512)

3 (n¼1870)

P for trend

75.6 (4.3)

75.7 (4.5)

75.5 (4.2)

75.0 (3.8)

<.01

Women

182 (47.4)

906 (52.0)

1392 (55.4)

905 (48.4)

.37

Ethnicity
White
African American

303 (78.9)
61 (15.9)

1249 (71.7)
423 (24.3)

1781 (70.9)
634 (25.2)

1270 (67.9)
(27.8)

<.001
<.001

Systolic blood pressure (mm Hg)

138.0 (19.5)

141.2 (19.7)

142.6 (19.7)

141.7 (19.1)

.01

Diastolic blood pressure (mm Hg)

79.4 (10.1)

90.7 (10.3)

80.7 (10.1)

79.6 (10.0)

.17

Hypertension

0 (0)

1253 (71.9)

2304 (91.7)

1849 (98.9)

<.001

Hypertension medication

0 (0)

971 (55.7)

1792 (71.3)

1506 (80.5)

<.001

Total cholesterol (mg/dL)

204.9 (39.7)

203.1 (39.1)

206.5 (41.4)

198.2 (42.2)

<.001

56.3 (17.5)

54.8 (16.9)

53.8 (15.7)

50.5 (15.0)

<.001

HDL-C (mg/dL)
Dyslipidemia

0 (0)

217 (12.5)

1415 (56.3)

1636 (87.5)

<.001

Statin

0 (0)

72 (4.1)

696 (27.7)

998 (53.4)

<.001

Diabetes

0 (0)

49 (2.8)

470 (18.7)

1138 (60.9)

<.001

Current smoking

0 (0)

224 (12.9)

835 (33.2)

1288 (68.9)

<.001

Reason for stress test
Chest pain
Shortness of breath
Rule out ischemia
Other

162 (42.2)
37 (9.6)
59 (15.4)
25 (32.8)

761
189
227
116

10-year ASCVD riskd
METs achieved
Achieving >10 METS

(43.7)
(10.8)
(13.0)
(32.5)

1052
318
334
169

(41.9)
(12.6)
(13.3)
(32.2)

716
252
254
126

(38.3)
(13.5)
(13.6)
(34.6)

<.001
<.001
.94
.47

24.7 (12.2)

28.9 (13.6)

34.2 (15.3)

44.7 (15.9)

<.001

6.4 (2.5)

6.2 (2.5)

6.2 (2.4)

6.3 (2.2)

.48

301 (17.2)

425 (16.7)

265 (14.1)

<.001

82 (21.4)

a

ASCVD, atherosclerotic cardiovascular disease; HDL-C, high-density lipoprotein cholesterol; METs, metabolic equivalents of task.
b
To convert cholesterol values to mmol/L, multiply by 0.0259.
c
Categorical variables are presented as number (%). Continuous variables are presented as mean (standard deviation).
d
ASCVD risk estimated using the 2013 American Heart Association/American College of Cardiology pooled cohort equations.

with 3 or more CVD risk factors (P¼.31;
Figure 3A). However, higher ﬁtness levels
were associated with signiﬁcantly longer survival, and during 15 years of follow-up, 669
(62.3%) patients in the highest ﬁtness group
were still alive compared with 1023 (35.4%)
patients in the lowest ﬁtness group (P<.001;
Figure 3B).
On multivariable adjusted Cox proportional hazards modeling (Table 2), there
was no signiﬁcant difference in the hazard
of death for patients with 3 or more CVD
risk factors compared with those with
0 CVD risk factors (hazard ratio [HR],
1.18; 95% CI, 0.97 to 1.43; P¼.10).
Compared with patients in the lowest ﬁtness
group, those with moderate ﬁtness had a
37% lower hazard of death (HR, 0.63; 95%
CI, 0.57 to 0.68), and those with high ﬁtness

had a 56% lower hazard of death (HR, 0.44;
95%, CI, 0.38 to 0.50). Within each CVD
risk factor group, there was approximately
a 35% reduction in hazard of death for those
with moderate ﬁtness and a more than 50%
reduction in hazard of death for those with
high ﬁtness compared with patients in the
lowest ﬁtness group (Supplemental Table 2,
available
online
at
http://www.
mayoclinicproceedings.org). In addition,
within each CVD risk factor group, there
was approximately a 15% lower hazard of
death for every 1 MET higher ﬁtness
achieved (P<.001). In sensitivity analyses,
we found no signiﬁcant difference in the results after excluding patients with a diagnosis of cancer at baseline, between women
and men, or after excluding patients who
died within the ﬁrst year of follow-up.
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% of individuals with in each risk factor group

100%
24.7%

28.4%

30.8%

39.6%

37.0%

26.6%

26.4%

5.4%

5.7%

7.6%

6–9.9 METs

≥10 METs

80%

60%
39.6%

40%

20%

0%

<6 METs

28.1%

Number of risk factors
1
2
≥3
0

FIGURE 1. Proportion of risk factors by metabolic equivalents of task (METs) group.

DISCUSSION
Among patients aged 70 years and older who
were free of known CVD, we found no signiﬁcant difference in long-term survival by
the number of traditional CVD risk factors,
but a higher ﬁtness level was strongly associated with a considerably lower mortality rate
across the spectrum of CVD risk factor
burden. These results highlight the utility
of ﬁtness as a risk stratiﬁcation tool among
older individuals, a group in whom risk
stratiﬁcation by traditional risk factors is
especially challenging. In addition, our ﬁndings add further evidence supporting the
importance of ﬁtness as a leading modiﬁable
risk factor among older persons.30,31
CVD risk stratiﬁcation based on traditional CVD risk factors is likely to be the
most commonly performed type of risk
assessment in routine clinical practice. It
may parenthetically also serve as a marker
of overall long-term prognosis, particularly
among older individuals, in whom CVD is
the leading cause of death. Commonly used
risk equations were derived using data
from predominantly middle-aged individuals
and are applied to older individuals, but this
pragmatic approach overlooks meaningful
physiologic differences between younger,
2380
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middle-aged, and older persons.32-34 For
instance, whereas age is heavily weighted
in the PCE and serves as a surrogate for
CVD risk factor duration, the relative
strength of the association between CVD
risk factors and outcomes signiﬁcantly declines with increasing age.35-37 This is largely
attributable to an increased prevalence of
CVD risk factors with increasing age, consistent with our ﬁnding that 94% of individuals
in this study had at least 1 CVD risk factor.
In addition, higher absolute event rates for
both CVD and non-CVD outcomes lead to
increased competing risks.2,38 Therefore,
variables that provide a measure of physiologic age rather than of chronologic age are
imperative for accurate risk stratiﬁcation
among older persons.39,40
Whereas the absence of CVD risk factors
among older patients is typically considered
a healthy phenotype, nearly no men older
than 65 years or women older than 70 years
are deemed low risk (10-year risk, <7.5%)
by the PCE, even in the absence of traditional CVD risk factors.41 Consequently,
this limited ability to identify healthy older
individuals is a weakness of commonly
used risk scores that are based on traditional
CVD risk factors.40 In contrast, our results

September 2021;96(9):2376-2385

n

https://doi.org/10.1016/j.mayocp.2020.12.039
www.mayoclinicproceedings.org
Downloaded for Anonymous User (n/a) at Henry Ford Hospital / Henry Ford Health System (CS North America) from ClinicalKey.com by
Elsevier on September 29, 2021. For personal use only. No other uses without permission. Copyright ©2021. Elsevier Inc. All rights reserved.

FITNESS AND CVD RISK FACTORS IN PERSONS 70 YEARS AND OLDER

70

60
Mortality rate per 1,000 person-years

demonstrate that higher ﬁtness identiﬁes
older patients with good long-term survival
regardless of their CVD risk factor burden.
Indeed, we found that patients with a high
ﬁtness level and 3 or more CVD risk factors
had a nearly 60% lower mortality rate
compared with patients without any CVD
risk factors but a low ﬁtness level.
The ability of higher ﬁtness to identify
older persons with good long-term survival is
an equally important strength compared with
the identiﬁcation of older persons with poor
long-term survival based on a low ﬁtness level.
This robustness to identify both low- and highrisk older persons is attributable to the dependence of ﬁtness on the global cardiovascular
health of an individual. Accordingly, ﬁtness
indirectly integrates measures of an individual’s myocardial function, coronary and peripheral atherosclerotic burden, vascular
endothelial function, and pulmonary function
in addition to other important risk predictors,
such as large-muscle strength and frailty.42-46
The measurement of traditional CVD risk factors does not cohesively integrate these physiologic measures, which is at least partly
responsible for the near absence of older individuals who are classiﬁed as low risk by
commonly used risk prediction models.
Previous attempts to improve risk stratiﬁcation in the elderly have shown only a
limited improvement compared with traditional risk scores. For example, Koller
et al47 used data from the Cardiovascular
Health Study and Rotterdam Study to
develop a coronary heart disease risk prediction model in persons 65 years of age and
older. Unfortunately, the risk score derived
from the elderly population showed only a
small improvement in risk prediction even
after the addition of novel risk factors, such
as ankle-brachial index, carotid intimal
thickness, and C-reactive protein level. Vliegenthart et al,48 also using data from the Rotterdam Study, investigated the utility of
coronary artery calcium (CAC) scoring for
risk prediction among individuals aged 70
years and older. Whereas they found a highly signiﬁcant relative association between
CAC and adverse outcomes, the addition of
CAC to a multivariate model showed an

50

40

30

20

10

0

0

1
2
Number of cardiovascular risk factors

≥3

Metabolic equivalents (METs)
6–9.9
≥10
<6

FIGURE 2. Age-adjusted mortality rate per 1000 person-years of follow-up
stratiﬁed by metabolic equivalents of task (METs) groups and number of risk
factors.

increase in the area under the curve of only
0.013 for CVD and 0.006 for mortality.
Although traditional CVD risk factors are
most strongly associated with CVD mortality, this study’s primary outcome of allcause mortality remains an important and
relevant outcome to examine. A better understanding of one’s long-term mortality
risk may be important for a patient’s selfawareness of overall health, identifying the
patient’s priorities for health care treatment
and quality of life along with identifying
long-term goals of care.49 Indeed, the National Institute for Health and Care Excellence highlighted the need to develop new
methods for robust mortality risk stratiﬁcation among patients with multiple chronic
diseases, which is common among older persons.50 Mortality risk prediction equations
such as QMortality, Hospital-Patient OneYear Mortality Risk, and the Johns Hopkins
Aggregated Diagnostic Groups predict only
short-term mortality (1-2 years) and contain
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METs categories
1.00

0.75

0.75

% survival

% survival

Number of risk factors
1.00

0.50

0.50

0.25

0.25
0

5

10

15

0

5

10

Years
1 RF

0 RF

15

Years
≥3 RF

2 RF

6–9.9 METs

<6 METs

A

≥10 METs

B

FIGURE 3. Kaplan-Meier survival stratiﬁed by (A) number of risk factors (RF) and (B) metabolic equivalents of task (METs) groups.

between 20 and 57 variables.49,51,52 Therefore, they have a relatively narrow utility in
routine patient care.
The proportion of deaths due to CVD
also increases sharply above the age of 70
years and accounts for approximately onethird of all deaths in this age group
(n¼508,804 deaths among persons 75
years old in the United States in 2016).53
Furthermore, the CVD risk factors included
in this study (eg, hypertension, dyslipidemia, diabetes, and smoking) are also associated with an increased risk of cancer,
Alzheimer disease, lung disease, and renal
disease, which combined with CVD deaths
accounts for 7 of the 10 leading causes of

death in this age group.53 Finally, all-cause
mortality is an objective outcome that is
not affected by misclassiﬁcation bias, which
is a signiﬁcant concern in the determination
for cause of death (especially CVD death)
among older individuals who typically have
multiple chronic diseases.54,55
Limitations of our analysis include that
patients in this study may have been healthier than patients referred for a noneexercise
stress test, which may limit the generalizability of our results. However, individuals
deemed unsuitable for a treadmill stress
test are likely to have an even lower ﬁtness
level and higher mortality rate. Submaximal
cardiorespiratory ﬁtness testing is an

TABLE 2. Hazard Ratios and 95% CIs of All-Cause Mortality by Number of Risk Factors and METs Groups
No. of risk factors

Unadjusted

P value

Model 1

P value

Model 2

0

Reference

1

1.16 (0.98-1.36)

.09

1.14 (0.97-1.35)

.12

1.06 (0.89-1.26)

.53

2

1.08 (0.92-1.27)

.35

1.12 (0.95-1.31)

.19

1.07 (0.90-1.28)

.46

3

1.10 (0.92-1.30)

.30

1.17 (0.98-1.39)

.08

1.18 (0.97-1.43)

.10

METs group
<6

Unadjusted

Reference

P value

P value

Reference

Model 1

Reference

P value

Reference

Model 2

P value

Reference

6-9.9

0.60 (0.55-0.66)

<.001

0.61 (0.56-0.67)

<.001

0.62 (0.57-0.68)

<.001

10

0.43 (0.38-0.49)

<.001

0.43 (0.38-0.49)

<.001

0.44 (0.38-0.50)

<.001

METs, metabolic equivalents of task.
Model 1: age, sex, race, reason for stress test.
Model 2: model 1 plus hypertensive medication use, statin use, and diabetes medication use.
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alternative measurement of ﬁtness that improves mortality risk stratiﬁcation and could
be considered among individuals unable to
perform a traditional treadmill stress test.56
In our risk factorebased analyses, we did
not examine how well an individual’s CVD
risk factors were controlled, although adjustment for risk factor treatment with medication did not signiﬁcantly change the
results. In addition, we did not examine
change in ﬁtness over time, although we
have previously demonstrated that most individuals have a stable relative ﬁtness level
during at least 4 years of follow-up.57
Strengths of this analysis include that more
than 50% of patients were women, and patients were observed for an average of 9.4
years. Survival was determined by Social Security Death Master File, which is nearly
identical to the Centers for Disease Control
and Prevention methodology for calculating
national death statistics in the United States
during this time period. In addition, ﬁtness
was directly measured using the Bruce protocol, which is the most commonly used
method for measuring ﬁtness in clinical
practice.
CONCLUSION
Among persons aged 70 years and older who
performed a treadmill stress test, an individual’s ﬁtness level but not the CVD risk factor
burden was signiﬁcantly associated with
long-term mortality risk across the spectrum
of CVD risk factor burden. In addition, a
high ﬁtness level identiﬁed older patients
with good long-term survival, even in the
presence of a signiﬁcant CVD risk factor
burden. These ﬁndings provide added support for the measurement of ﬁtness as a simple and low-cost method to improve risk
stratiﬁcation among older persons.
SUPPLEMENTAL ONLINE MATERIAL
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